Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Arne Kolstad; Anna Laurell; Mats Jerkeman; Kirsten Gronbaek; Erkki Elonen; Riikka Räty; Lone Bredo Pedersen; Annika Loft; Trond Velde Bogsrud; Eva Kimby; Per Boye Hansen; Unn-Merete Fagerli; Herman Nilsson-Ehle; Grete Fossum Lauritzsen; Anne Kristine Lehmann; Christer Sundstrom; Marja-Liisa Karjalainen-Lindsberg; Elisabeth Ralfkiaer; Mats Ehinger; Jan Delabie; Hans Bentzen; Jukka Schildt; Kamelia Kostova-Aherdan; Henrik Frederiksen; Peter de Nully Brown; Christian H. Geisler; Nordic Lymphoma Grp

doi:10.1182/blood-2013-12-541953

Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Arne Kolstad, Anna Laurell, Mats Jerkeman, Kirsten Gronbaek, Erkki Elonen, Riikka Räty, Lone Bredo Pedersen, Annika Loft, Trond Velde Bogsrud, Eva Kimby, Per Boye Hansen, Unn-Merete Fagerli, Herman Nilsson-Ehle, Grete Fossum Lauritzsen, Anne Kristine Lehmann, Christer Sundstrom, Marja-Liisa Karjalainen-Lindsberg, Elisabeth Ralfkiaer, Mats Ehinger, Jan DelabieHans Bentzen, Jukka Schildt, Kamelia Kostova-Aherdan, Henrik Frederiksen, Peter de Nully Brown, Christian H. Geisler, Nordic Lymphoma Grp

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Blood
Vuosikerta	123
Numero	19
Sivut	2953-2959
Sivumäärä	7
ISSN	0006-4971
DOI - pysyväislinkit	https://doi.org/10.1182/blood-2013-12-541953
Tila	Julkaistu - 8 toukok. 2014
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet

Pääsy asiakirjaan

10.1182/blood-2013-12-541953

Siteeraa tätä

Kolstad, A., Laurell, A., Jerkeman, M., Gronbaek, K., Elonen, E., Räty, R., Pedersen, L. B., Loft, A., Bogsrud, T. V., Kimby, E., Hansen, P. B., Fagerli, U-M., Nilsson-Ehle, H., Lauritzsen, G. F., Lehmann, A. K., Sundstrom, C., Karjalainen-Lindsberg, M-L., Ralfkiaer, E., Ehinger, M., ... Nordic Lymphoma Grp (2014). Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma. Blood, 123(19), 2953-2959. https://doi.org/10.1182/blood-2013-12-541953

@article{fa78ef836c4e4e23945a7184af8d1222,

title = "Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma",

keywords = "POSITRON-EMISSION-TOMOGRAPHY, Y-90 IBRITUMOMAB TIUXETAN, PROGNOSTIC INDEX MIPI, NON-HODGKINS-LYMPHOMA, INTERNATIONAL WORKSHOP, MOLECULAR REMISSION, RESPONSE CRITERIA, PHASE-II, IMMUNOCHEMOTHERAPY, LEUKEMIA, 3121 General medicine, internal medicine and other clinical medicine",

author = "Arne Kolstad and Anna Laurell and Mats Jerkeman and Kirsten Gronbaek and Erkki Elonen and Riikka R{\"a}ty and Pedersen, {Lone Bredo} and Annika Loft and Bogsrud, {Trond Velde} and Eva Kimby and Hansen, {Per Boye} and Unn-Merete Fagerli and Herman Nilsson-Ehle and Lauritzsen, {Grete Fossum} and Lehmann, {Anne Kristine} and Christer Sundstrom and Marja-Liisa Karjalainen-Lindsberg and Elisabeth Ralfkiaer and Mats Ehinger and Jan Delabie and Hans Bentzen and Jukka Schildt and Kamelia Kostova-Aherdan and Henrik Frederiksen and Brown, {Peter de Nully} and Geisler, {Christian H.} and {Nordic Lymphoma Grp}",

year = "2014",

month = may,

day = "8",

doi = "10.1182/blood-2013-12-541953",

language = "English",

volume = "123",

pages = "2953--2959",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "19",

}

Kolstad, A, Laurell, A, Jerkeman, M, Gronbaek, K, Elonen, E , Räty, R, Pedersen, LB, Loft, A, Bogsrud, TV, Kimby, E, Hansen, PB, Fagerli, U-M, Nilsson-Ehle, H, Lauritzsen, GF, Lehmann, AK, Sundstrom, C, Karjalainen-Lindsberg, M-L, Ralfkiaer, E, Ehinger, M, Delabie, J, Bentzen, H, Schildt, J, Kostova-Aherdan, K, Frederiksen, H, Brown, PDN, Geisler, CH & Nordic Lymphoma Grp 2014, 'Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma', Blood, Vuosikerta 123, Nro 19, Sivut 2953-2959. https://doi.org/10.1182/blood-2013-12-541953

TY - JOUR

T1 - Nordic MCL3 study

T2 - Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

AU - Kolstad, Arne

AU - Laurell, Anna

AU - Jerkeman, Mats

AU - Gronbaek, Kirsten

AU - Elonen, Erkki

AU - Räty, Riikka

AU - Pedersen, Lone Bredo

AU - Loft, Annika

AU - Bogsrud, Trond Velde

AU - Kimby, Eva

AU - Hansen, Per Boye

AU - Fagerli, Unn-Merete

AU - Nilsson-Ehle, Herman

AU - Lauritzsen, Grete Fossum

AU - Lehmann, Anne Kristine

AU - Sundstrom, Christer

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Ralfkiaer, Elisabeth

AU - Ehinger, Mats

AU - Delabie, Jan

AU - Bentzen, Hans

AU - Schildt, Jukka

AU - Kostova-Aherdan, Kamelia

AU - Frederiksen, Henrik

AU - Brown, Peter de Nully

AU - Geisler, Christian H.

AU - Nordic Lymphoma Grp

PY - 2014/5/8

Y1 - 2014/5/8

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - Y-90 IBRITUMOMAB TIUXETAN

KW - PROGNOSTIC INDEX MIPI

KW - NON-HODGKINS-LYMPHOMA

KW - INTERNATIONAL WORKSHOP

KW - MOLECULAR REMISSION

KW - RESPONSE CRITERIA

KW - PHASE-II

KW - IMMUNOCHEMOTHERAPY

KW - LEUKEMIA

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1182/blood-2013-12-541953

DO - 10.1182/blood-2013-12-541953

M3 - Article

VL - 123

SP - 2953

EP - 2959

JO - Blood

JF - Blood

SN - 0006-4971

IS - 19

ER -